IL5 and melanoma: In 2012, Ikutani and coworkers reported that, in a mouse model of melanoma lung metastasis, ILC2s responded to melanoma cells by secreting IL-5, which in turn promoted eosinophil recruitment and activation, thus counteracting metastasization [51] (Figure 1B).